In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-7 of 7 for your search:
Drug:  monoclonal antibody Ch14.18
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2009-01064, ANBL0032, U10CA098543, U10CA030969, COG-ANBL0032, COG-P9842, NCT00026312
2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 20 at diagnosis
Sponsor: Other
Protocol IDs: CDR0000069191, SIOP-EUROPE-HR-NBL-1, ESIOP, EU-20148, NCT00030719
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 month to 21 years
Sponsor: Other
Protocol IDs: HR-NBL-1 (1.5)/SIOPEN, NCT01704716
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 8 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: DIV-NB-201, NCT01592045
5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: 012010, 2009-018077-31, NCT01701479
6.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: Children
Sponsor: NCI, Other
Protocol IDs: ANBL1221, COG-ANBL1221, NCT01767194
7.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-02011, NANT N2011-04, P01CA081403, NCT01711554
New Search